Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Label Inspection for Transdermal Patches

Posted on By

SOP for Label Inspection for Transdermal Patches

Standard Operating Procedure for Label Inspection for Transdermal Patches

1) Purpose

To define procedures for inspecting labels used in the packaging of transdermal patches to ensure accuracy, consistency, and compliance with regulatory requirements.

2) Scope

This SOP applies to the quality control department responsible for inspecting labels during the packaging process of transdermal patches.

3) Responsibilities

3.1 Quality Control Inspector: Perform label inspections according to defined procedures.
3.2 Production Supervisor: Ensure labels are applied correctly and in accordance with approved artwork.
3.3 QA Personnel: Review and approve label inspection procedures and reports.
3.4 Regulatory Affairs: Ensure compliance with labeling regulations and requirements.

See also  SOP for Batch Reconciliation in Transdermal Patches Production

4) Procedure

4.1 Label Inspection Setup:

4.1.1 Verify the availability of correct label stock and artwork specifications.

4.1.2 Prepare inspection area with adequate lighting and magnification tools if necessary.

4.2 Inspection Process:

4.2.1 Retrieve labeled transdermal patches from the packaging line at predefined intervals.

4.2.2 Compare labels against the approved artwork and specifications.

4.2.3 Inspect for correct text, fonts, colors, barcodes, lot numbers, and expiration dates.

4.3 Defect Identification:

4.3.1 Identify and document any labeling defects or discrepancies.

4.3.2 Classify defects

according to severity and impact on product quality and regulatory compliance.

4.4 Reconciliation:

4.4.1 Reconcile inspected labels with packaging records and batch documentation.

See also  SOP for Documentation in Transdermal Patches Production

4.4.2 Verify that all required labeling information is present and legible.

4.5 Documentation:

4.5.1 Record inspection findings, including any deviations or non-conformities.

4.5.2 Maintain accurate and comprehensive documentation of label inspections.

4.6 Final Approval:

4.6.1 QA personnel review inspection reports and approve labels for use based on compliance with specifications.

4.6.2 Release inspected batches for further packaging and distribution.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QA: Quality Assurance

6) Documents, if any

Label Inspection Checklists
Label Inspection Reports
Batch Packaging Records

7) Reference, if any

FDA Code of Federal Regulations, Title 21 – Food and Drugs
ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

See also  SOP for Process Simulation Testing in Transdermal Patches Production

8) SOP Version

Version 1.0

Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Formulation Development for Lotions
Next Post: Injectables: SOP for Validation of Analytical Methods

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version